| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |